Conavi Expands Leadership Team to Support Next Phase of U.S. Commercialization

Mark Quick Appointed Chief Financial Officer, Bringing Extensive Public Company Capital Markets Expertise -- Current CFO, Stefano Picone, will take on a Transitional Strategic Role to Support Leadership Continuity During Growth Phase -- Leadership additions follow submission of next-generation Novasight™ to the FDA for 510(k) clearance - TORONTO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Conavi Medical (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and ...